For instance, in gastric, colon, and breast cancers [38–40], ALKBH5 promotes tumorigenesis, whereas in esophageal, hepatocellular carcinoma, osteosarcoma, ALKBH5 reduces cancer malignancy [41–43]. Here, ALKBH5 is linked to osteosarcoma.